Gossamer Bio, Inc. 5.0% 01-JUN-2027Gossamer Bio, Inc. 5.0% 01-JUN-2027Gossamer Bio, Inc. 5.0% 01-JUN-2027

Gossamer Bio, Inc. 5.0% 01-JUN-2027

No trades
See on Supercharts

Key terms


Outstanding amount
‪200.00 M‬USD
Face value
1,000.00USD
Minimum denomination
1,000.00USD
Coupon
5.00% (Fixed)
Coupon frequency
Semi-annual
Yield to maturity
40.23%
Maturity date
Jun 1, 2027
Term to maturity
2 years

About Gossamer Bio, Inc. 5.0% 01-JUN-2027


Sector
Health Technology
Issue date
May 21, 2020
FIGI
BBG00TZ4H6H9
Gossamer Bio, Inc. engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. Its primary product candidate, GB001, is intended for the treatment of moderate-to-severe eosinophilic asthma and other allergic conditions. The company was founded by Faheem Hasnain and Sheila Gujrathi in 2015 and is headquartered in San Diego, CA.
Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.